Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 11,890.2%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 11,890.16% |
Sezzle Inc Common Stock (SEZL) | 162.7% |
Dave (DAVE) | 138.35% |
Oklo (OKLO) | 134.43% |
D-Wave Quantum (QBTS) | 108% |
TransMedics (TMDX) | 101.16% |
Orla Mining (ORLA) | 98.93% |
Centrus Energy (LEU) | 94.68% |
H&E Equipment Services (HEES) | 91.21% |
Root (ROOT) | 87.79% |
New Gold (NGD) | 86.06% |
Akero Therapeutics (AKRO) | 83.8% |
Verona Pharma PLC ADR (VRNA) | 81.53% |
Sibanye Gold Ltd ADR (SBSW) | 80.94% |
ODDITY Tech Ltd Class A Ordinary Shares (ODD) | 78.8% |
SSR Mining (SSRM) | 78.41% |
Harmony Gold Mining (HMY) | 77.68% |
StoneCo (STNE) | 75.46% |
Soleno Therapeutics (SLNO) | 72.75% |
Nuscale Power (SMR) | 71.19% |
Inter & Co Inc Class A Common Shares (INTR) | 69.51% |
Companhia Paranaense de Energia - COPEL (ELPC) | 66.74% |
Hertz Global (HTZ) | 66.58% |
Sandstorm Gold Ltd N (SAND) | 65.49% |
Palomar (PLMR) | 65.41% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
